Accotest(SH:688200) Zheng Quan Zhi Xing·2025-06-09 10:34Core Viewpoint - The company plans to issue convertible bonds to unspecified investors, which may dilute immediate returns and will implement measures to compensate for this dilution [1][5][10] Financial Impact of the Issuance - The company analyzed the impact of the bond issuance on key financial metrics under various assumptions regarding net profit growth for 2025, including scenarios of 0%, 5%, and 10% growth [3][4] - The projected net profit for 2025 is estimated at approximately 340 million yuan, with diluted earnings per share (EPS) potentially decreasing from 2.47 yuan to 2.42 yuan under certain conditions [3][4] Necessity and Reasonableness of the Issuance - The funds raised will be used for projects that enhance the company's core competitiveness and sustainable development capabilities, particularly in the development of self-researched ASIC chip testing systems [5][7] Relationship of Fundraising Projects to Existing Business - The fundraising projects are closely aligned with the company's existing semiconductor automated testing system business, focusing on the development of a new generation of testing systems based on self-researched ASIC chips [6][7] Company’s Preparedness in Personnel, Technology, and Market - The company has a strong personnel base with 379 R&D staff, accounting for 48.59% of total employees, ensuring adequate talent for project development [8] - Significant technological advancements have been made, with over 7,500 units of testing systems installed globally, supporting the development of ASIC chips [8][9] - The company has established long-term partnerships with major clients in the semiconductor industry, enhancing its market position [9][10] Measures to Mitigate Dilution of Immediate Returns - The company will enhance profitability and expand business scale, ensuring effective use of raised funds and improving governance structures to protect shareholder interests [10][11][12] - A commitment from major stakeholders to ensure the effectiveness of measures to compensate for any dilution of returns has been made [12][13] Approval Process for the Issuance - The issuance plan has undergone multiple rounds of approval, including board meetings and a shareholder meeting, ensuring compliance with regulatory requirements [13][14]